Anamnestic factors; Breast density; Polygenic risk score; Screening; Breast cancer; Early Detection of Cancer; Female; Humans; Precision Medicine; Risk Assessment; Risk Factors; Breast Neoplasms/diagnosis; Breast Neoplasms/epidemiology; Breast Neoplasms; Medicine (all)
Résumé :
[en] Breast cancer is the leading cause of neoplastic death in women around the world. In the era of personalized medicine, legitimately awaited by our patients, the future of breast cancer screening will depend on an individual-based risk assessment, making it possible to better adapt the age of onset, frequency and the type of examinations useful for this screening. This article reviews the three broad categories of highest risk factors available to establish a risk score appropriate for each patient. [fr] Le cancer du sein est la première cause de mortalité par néoplasie chez la femme de par le monde. À l’ère d’une médecine personnalisée, légitimement attendue par nos patientes, l’avenir du dépistage du cancer du sein passera par une évaluation du risque sur base individuelle, permettant d’adapter, au mieux, l’âge de début ainsi que la fréquence et le type des examens utiles pour ce dépistage. Cet article passe en revue les trois grandes catégories de facteurs de plus haut risque disponibles pour établir un score de risque adapté à chaque patiente.
Disciplines :
Radiologie, médecine & imagerie nucléaire
Auteur, co-auteur :
Bleret, Valerie ; Centre Hospitalier Universitaire de Liège - CHU > > Service de sénologie
Cusumano, P; Service de Sénologie, CHU Liège, Belgique
Danthine, Denis ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiodiagnostic
Desreux, Joëlle ; Centre Hospitalier Universitaire de Liège - CHU > > Service de sénologie
HOUET, Elise ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco
REMACLE, Nadine ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiodiagnostic
Lifrange, Eric ; Centre Hospitalier Universitaire de Liège - CHU > > Service de sénologie
Langue du document :
Français
Titre :
Cancer du sein : évaluation individualisée du risque en vue d’un dépistage sur mesure.
Titre traduit :
[en] Breast cancer : individualized risk assessment for tailor-made screening.
Vachon C, Pankratz V, Scott C et al. The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst 2015;107:dju397.
Cuzick J, Brentnall A, Dowsett M. SNPs for breast cancer risk assessment. Oncotarget 2017;8:99211-12.
Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med 2000;342:564-71.
Overholser L, Shagisultanova E, Rabinovitch RA, et al. Breast cancer following radiation for Hodgkin lymphoma: clinical scenarios and risk-reducing strategies. Oncology 2016;30:1063-70.
Louro J, Posso M, Hilton Boon M, et al. A systematic review and quality assessment of individualised breast cancer risk prediction models. Br J Cancer 2019;121:76-85.
Terry M, Liao Y, Whittemore A, et al. 10-year performance of four models of breast cancer risk: a validation study. Lancet Oncol 2019;20:504-17.
Esserman LJ, WISDOM Study, Athena Investigators WISDOM. Study: breaking the deadlock in breast cancer screening debate. NPJ Breast Cancer 2017;3:34.
My Personalized Breast Screening (MyPeBS). En ligne: https://clinicaltrials.gov/ct2/show/NCT03672331 - Dernière consultation le 19/03/2021.
Spak A, Plaxco J, Santiago L, et al. BI-RADS® fifth edition: A summary of changes. Diagn Interv Imaging 2017;98:179-90.
Von Euler-Chelpin M, Lillholm M, Vejborh I, et al. Sensitivity of screening mammography by density and texture: a cohort study from a population-based screening program in Denmark. Breast Cancer Res 2019;21:111.
Phi XA, Tagliafico A, Houssami N, et al. Digital breast tomosynthesis for breast cancer screening and diagnosis in women with dense breasts - a systematic review and meta-analysis. BMC Cancer 2018;18:380.
Lee C, Chen L, Elmore J. Risk-based breast cancer screening: implication of breast density. Med Clin North Am 2017;101:725-41.
Price ER, Hargreaves J, Lipson JA, et al. The Californian Breast Density Information Group: a collaborative response to the issues of breast density, breast cancer risk, and breast density notification legislation. Radiology 2013;269:887-92.
Swenen L, Bleret V, Lifrange E, Compère S. Nouvelle approche du dépistage du cancer du sein. Rev Med Liege 2017;72:87-91.
Easton DF, Pharoah PD, Antoniou AC, et al. Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 2015;372:2243-57.
Mavaddat N, Pharoa PD, Michailidou K, et al. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst 2015;107:djv036.
Chatterjee N, Garcia-Closas M. Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat Rev Genet 2016;17:392-406.
Vachon C, Scott C, Tamimi R, et al. Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk. Breast Cancer Res 2019;21:68.
van Veen EN, Brentnall AR, Byers H, et al. Use of singlenucleotid polymorphisms and mammographic density plus classic risk factors for breast cancer risk prediction. JAMA Oncol 2018;4:476-82.
Zhang X, Rice M, Tworoger SS, et al. Addition of a polygenic risk score, mammographic density and endogenous hormones to existing breast cancer risk prediction models: a nested case-control study. PloS Med 2018;15:e1002644.
Mavaddat N, Michailidou K, Dennis J, et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet 2019;104:1-14.
Yanes T, Young MA, Meiser B, et al. Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field. Breast Cancer Res 2020;22:21.
Jérusalem G, Collignon J, Josse,Cl et al. Cancer du sein: de la thérapie ciblée à la médecine personnalisée. Rev Med Liege 2015;70:269-76.
